AcquisitionOther
Innoviva, Inc. acquired La Jolla Pharmaceutical Company
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Innoviva, Inc. -> La Jolla Pharmaceutical Company · $6.23
This acquisition strengthens Innoviva’s portfolio in infectious diseases, anchored by the company’s recent purchase of Entasis Therapeutics Holdings Inc., an advanced late-stage clinical biopharmaceutical company focused on the discovery and development of nov
Open source record (SEC) ↗